Neurocrine Biosciences reported $1.42B in Equity Capital and Reserves for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Equity Capital And Reserves Change
Acadia Pharmaceuticals ACAD:US $ 444.8M 96.1M
Acorda Therapeutics ACOR:US $ 87.91M 39.64M
Agios Pharmaceuticals AGIO:US $ 1124.07M 83.38M
ALKERMES ALKS:US $ 1082.32M 6.93M
Alnylam Pharmaceuticals ALNY:US $ 176.04M 225.13M
Amgen AMGN:US $ 2419M 1503M
Biogen BIIB:US $ 11872.5M 630.2M
Biomarin Pharmaceutical BMRN:US $ 4504.81M 113.49M
Cytokinetics CYTK:US $ 111.41M 4.85M
Dynavax Technologies DVAX:US $ 422.8M 135.32M
Enanta Pharmaceuticals ENTA:US $ 358.58M 25.8M
Exelixis EXEL:US $ 2293.85M 83.24M
Gilead Sciences GILD:US $ 20215M 288M
Halozyme Therapeutics HALO:US $ 260.26M 63.3M
Intercept Pharmaceuticals ICPT:US $ -369.83M 1.93M
Intra Cellular Therapies ITCI:US $ 792.75M 374.86M
IONIS PHARMACEUT IONS:US $ 709.57M 62.16M
Nektar Therapeutics NKTR:US $ 458.73M 149.16M
Neurocrine Biosciences NBIX:US $ 1423.4M 32.3M
Prothena PRTA:US $ 438.89M 27.16M
Regeneron Pharmaceuticals REGN:US $ 20687.8M 773.1M
Repligen RGEN:US $ 1805.36M 38.96M
Rigel Pharmaceuticals RIGL:US $ -3.68M 10.48M
Sarepta Therapeutics SRPT:US $ 726.46M 130.43M
Teva Pharmaceutical TEVA:IT 9.04B 307M
Ultragenyx Pharmaceutical RARE:US $ 678.07M 118.35M
Vertex Pharmaceuticals VRTX:US $ 11933.5M 1026.5M
Xoma XOMA:US $ 134.96M 4.97M
YTE INCY:US $ 4085.06M 221.99M